AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Alpha Cognition Inc. will participate in a virtual fireside chat hosted by Titan Partners on December 2, 2025, to discuss commercialization efforts and research initiatives for its therapies for neurodegenerative diseases. The company's CEO, Michael McFadden, will be the participant, and Boris Peaker, Managing Director of Titan Partners, will be the host. The discussion will focus on accelerating commercial adoption of the company's treatments, including its FDA-approved new generation acetylcholinesterase inhibitor, ZUNVEYL.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet